Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Serum Neopterin Monitoring in Hepatitis B e Antigen Positive Chronic Type B Hepatitis with Recurrent Acute Exacerbation

Serum Neopterin Monitoring in Hepatitis B e Antigen Positive Chronic Type B Hepatitis with... Summary Activation of cellular immunity, mainly cytotoxic T cells, plays an important role in the · mechanisms of cyclic acute exacerbation of hepatocellular damage (AE) in hepatitis B virus (HBV) carriers. Monitoring of the dynamics of immunoreactivity is clinically important to manage the patients and recognize the mechanism of liver damage. Serum neopterin has been widely- recognized as a marker of actiyation of cell-mediated immunity. We observed the clinical course of five hepatitis Be antigen I HBeAg ) positive HBV carriers with recurrent AE for mean eighteen months by monitoring of serum neopterin using a RIA kit. Alanine amino transferase (ALT) and HBeAg were also measured serially as markers for hepatocne necrosis and viral replication, respectively During follow-up period. each patient had several episodes of AE alternating with normal or nearly normal liver function. The levels of serum neopterin changed dynamically related to those of HBeAg and ALT Temporal analysis of these makers before, during and after the episodes of AE showed a close involvement of the viral replication prior to the hepatocellular injury as well as the activation of cellular immunity following the viral replication. Immunological monitoring of serum neopterin could provide useful information about the dynamic interaction between virus replication, cellular immunoreactivity and hepatocellular damage. It was thought that serum neopterin can be used as a complementary marker to follow and manage chronic hepatitis B patients. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pteridines de Gruyter

Serum Neopterin Monitoring in Hepatitis B e Antigen Positive Chronic Type B Hepatitis with Recurrent Acute Exacerbation

Download PDF
6 pages

Loading next page...
 
/lp/de-gruyter/serum-neopterin-monitoring-in-hepatitis-b-e-antigen-positive-chronic-Ddmb36rO1a

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
de Gruyter
Copyright
Copyright © 1999 by the
ISSN
0933-4807
eISSN
2195-4720
DOI
10.1515/pteridines.1999.10.4.207
Publisher site
See Article on Publisher Site

Abstract

Summary Activation of cellular immunity, mainly cytotoxic T cells, plays an important role in the · mechanisms of cyclic acute exacerbation of hepatocellular damage (AE) in hepatitis B virus (HBV) carriers. Monitoring of the dynamics of immunoreactivity is clinically important to manage the patients and recognize the mechanism of liver damage. Serum neopterin has been widely- recognized as a marker of actiyation of cell-mediated immunity. We observed the clinical course of five hepatitis Be antigen I HBeAg ) positive HBV carriers with recurrent AE for mean eighteen months by monitoring of serum neopterin using a RIA kit. Alanine amino transferase (ALT) and HBeAg were also measured serially as markers for hepatocne necrosis and viral replication, respectively During follow-up period. each patient had several episodes of AE alternating with normal or nearly normal liver function. The levels of serum neopterin changed dynamically related to those of HBeAg and ALT Temporal analysis of these makers before, during and after the episodes of AE showed a close involvement of the viral replication prior to the hepatocellular injury as well as the activation of cellular immunity following the viral replication. Immunological monitoring of serum neopterin could provide useful information about the dynamic interaction between virus replication, cellular immunoreactivity and hepatocellular damage. It was thought that serum neopterin can be used as a complementary marker to follow and manage chronic hepatitis B patients.

Journal

Pteridines – de Gruyter

Published: Nov 1, 1999

There are no references for this article.